Acquisition (Details) (USD $)	6 Months Ended	1 Months Ended
	Dec. 31, 2012	Jul. 31, 2012 Morphormics	Dec. 31, 2012 Morphormics	Jul. 16, 2012 Morphormics	Jun. 30, 2012 Morphormics
Acquisition
Acquisition of remaining outstanding shares (as a percent)				90.00%
Outstanding shares held prior to acquisition (as a percent)				10.00%
Fair value of outstanding shares prior to acquisition				$ 700,000	$ 0
Purchase consideration payable on April 16, 2013			900,000
Total acquired equity interest (as a percent)				100.00%
Purchase price
Cash paid and payable				5,385,000
Gain recognized on pre existing outstanding shares	662,000	662,000
Total purchase price				6,047,000
Purchase price allocation
Cash and cash equivalents				668,000
Accounts receivable				283,000
Other current assets				7,000
Amortizable intangible assets - developed technology				5,100,000
Goodwill				77,000
Accrued compensation				$ (88,000)